About The School

TIME.com - Ketamine: Leading the Way Toward Fast-Acting Antidepressants

New York

– January 8, 2013 ––

It’s an anesthetic popular with veterinarians, but the latest studies show ketamine also shows promise as a potential antidepressant. Researchers such as Dr. James Murrough, assistant professor of psychiatry at the Icahn School of Medicine at Mount Sinai, are conducting clinical trials of ketamine as a treatment for depression but are reluctant to offer the drug outside of research. “I’m excited because it has potential, but it’s not quite ready yet,” Dr. Murrough says. If the studies do support the safety and effectiveness of ketamine or ketamine-like agents for treating depression, however, these drugs could become an important part of the psychiatric arsenal in addressing symptoms of mood disorders quickly.
- Dr. James Murrough, Assistant Professor, Psychiatry and Neuroscience, Icahn School of Medicine at Mount SinaiLearn more